ag真人平台官方
Other Affiliated Sites
Simplified Chinese
Traditional Chinese
ag真人平台官方:About Hepalink
ag真人平台官方:Group Profile
ag真人平台官方:Corporate Philosophy
ag真人平台官方:Milestones
ag真人平台官方:Leadership Team
ag真人平台官方:Scientific Advisory Board
ag真人平台官方:Our Businesses
Heparin Business
ag真人平台官方:Global Industrial Chain
ag真人平台官方:Global Heparin Injections Business
Product Profile
ag真人平台官方:CDMO Services
ag真人平台官方:Innovative Drugs
ag真人平台官方:Global Manufacturing
ag真人平台官方:Company News
ag真人平台官方:Investor Relations
ag真人平台官方:Corporate Governance
Disclosures
ag真人平台官方:Stock Information
ag真人平台官方:IR Events
IR Contact
Join Us
Career Development
ag真人平台官方:Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
ag真人平台官方:A-Share Information
ag真人平台官方:H-Share Information
ag真人平台官方:A-Share Information
ag真人平台官方:H-Share Information
2019.02.02
关于第三期员工持股计划完成股票购买的公告
2019.01.29
关于第三期员工持股计划的进展公告
2018.12.29
招商资管-公司员工持股计划单一资产管理合同
2018.12.25
北京市中伦(深圳)律师事务所关于公司第三期员工持股计划的法律意见书
第一页
上一页
51
52
53
54
55
下一页
最后一页
About Hepalink
ag真人平台官方:Group Profile
ag真人平台官方:Corporate Philosophy
Milestones
ag真人平台官方:Leadership Team
ag真人平台官方:Scientific Advisory Board
Our Businesses
ag真人平台官方:Heparin Business
ag真人平台官方:CDMO Services
ag真人平台官方:Innovative Drugs
ag真人平台官方:Global Manufacturing
ag真人平台官方:Company News
Investor Relations
ag真人平台官方:Corporate Governance
Disclosures
ag真人平台官方:Stock Information
ag真人平台官方:IR Events
ag真人平台官方:IR Contact
Join Us
ag真人平台官方:Career Development
ag真人平台官方:Contact Us
Official WeChat Account
ag真人平台官方:Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.